Ranolazine for Improving Symptoms of Palpitations
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT01495520
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Registry
-
NCT01495520
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT01495520. Randomized; triple masking; primary purpose treatment. Start 2014-01 (registry gives no type); primary completion 2014-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Ranolazine for Improving Symptoms of Palpitations
- Acronym
- RYPPLE
- Condition
- Ischemic Heart Disease
- Intervention (Drug)
- Ranolazine
- Intervention (Drug)
- Placebo
- Lead sponsor
- University of Roma La Sapienza
Record details
- Record id
cardio:ct-nct01495520- Content hash
6df76917b84f9589142bb9c4ad0c93925f992e4a2dc06c0149acc06394c4566c